pharma-jonpi.blogspot.com.es
🖥 Status: up
🕒 Response Time: 0.377 sec
⬅️ Response Code: 200
Data analysis shows that 5 uptime tests were conducted for pharma-jonpi.blogspot.com.es throughout the 2 553 day period starting on August 18, 2019. Pharma-jonpi.blogspot.com.es was online 5 times out of all checks performed, with a code 200 response on the latest test conducted on May 25, 2026. Inspections conducted as of August 15, 2026, revealed no instances of pharma-jonpi.blogspot.com.es's unavailability. There were no errors reported in any of the responses as of August 15, 2026, based on the received replies. For pharma-jonpi.blogspot.com.es, the May 25, 2026, response time was 0.377 seconds, contrasted by a 1.630 seconds average.
5
Last Updated: May 25, 2026
Pharma-jonpi overview
- Domain
- pharma-jonpi.blogspot.com.es
- Title
- Pharma Jonpi . / 1.1 / .
- Description
- DESPUES DE 18 AÑOS CON SOLO TOPOTECAN CON FULL APPROVAL EN EEUU COMO TREATMENT 2a LÍNE SCLC-ES ... LA USFDA ACABA DE APROBAR AL TARLATAMAB CON FULL APPROVAL ... POR LO QUE ES YA EL NEW TREATMENT STÁNDARD EN EEUU . TIENE APROBACIÓNES ACELERADAS EN CANADA , UK, COREA ... Y EN DÍAS PODRÍA ALCANZAR LA APROBACIÓN TAMBIÉN EN CHINA QUE EN JULIO 2025, LA NMPA ACEPTÓ LA SOLICITUD DE REGISTRO (NDA) PARA TARLA OTORGÁNDOLE ADEMAS LA REVISIÓN PRIORITARIA . LA EMA TAMBIÉN LO ESTÁ YA EVALUANDO .
- Main Topic
- Pharma Jonpi . / 1.1 / .
FDA Approves Keytruda Qlex Subcutaneous Injection for Adult and Pediatric Patients With Solid Tumors
KEYTRUDA Shows Survival Edge Over TECENTRIQ, OPDIVO in Older Patients With LUNG Cancer . - J Site Status Rank
- 513 341
- Search Wikipedia
- pharma-jonpi.blogspot.com.es
- Alternatives
- alternatives to pharma-jonpi.blogspot.com.es
- Recently checked
- sunburst.com
srpskijezickiatelje.com
Last Updated: June 28, 2026
Status: up
Response Time: 0.707 sec
Response Code: 200
nikhilvijayan.com
Last Updated: August 28, 2021
Status: up
Response Time: 1.589 sec
Response Code: 200
irisvaneijk.com
Last Updated: January 24, 2019
Status: up
Response Time: 1.204 sec
Response Code: 200
Pharma-jonpi.blogspot.com.es
status check request map as of August 15, 2026
Country report for pharma-jonpi.blogspot.com.es as of August 15, 2026
| United States | 100.00% | ||||||||
| 17:14 | |||||||||
| Site | Total Checks | Last Modified |
|---|---|---|
| 5 | February 12, 2019 | |
| 3 | March 5, 2026 | |
 pharma-jonpi.blogspot.com.es | 5 | August 18, 2019 |
| 2 | January 15, 2025 | |
| 12 | September 14, 2021 |
Zojirushi.com | Pharma-jonpi.blogspot.com.es | ||||
|---|---|---|---|---|---|
General SEO Report
| Page Title | Page Title tips for pharma-jonpi.blogspot.com.es: An optimized website title is fundamental to attracting qualified traffic; incorporate your target keywords strategically near the beginning of the title to enhance SEO relevance, maintain a character count below the 60-character threshold to prevent truncation in search engine listings, and ensure the title accurately describes the specific, valuable information or service offered by the target webpage |
|---|---|
| Pharma Jonpi . / 1.1 / . Length: 24 characters | |
| Meta Description | Meta Description tips for pharma-jonpi.blogspot.com.es: Formatting your meta description text correctly within the HTML <meta name="description"> tag ensures search engines can read it properly and increases its potential impact; avoid overly complex structures or code within the tag itself. |
| DESPUES DE 18 AÑOS CON SOLO TOPOTECAN CON FULL APPROVAL EN EEUU COMO TREATMENT 2a LÍNE SCLC-ES ... LA USFDA ACABA DE APROBAR AL TARLATAMAB CON FULL APPROVAL ... POR LO QUE ES YA EL NEW TREATMENT STÁNDARD EN EEUU . TIENE APROBACIÓNES ACELERADAS EN CANADA , UK, COREA ... Y EN DÍAS PODRÍA ALCANZAR LA APROBACIÓN TAMBIÉN EN CHINA QUE EN JULIO 2025, LA NMPA ACEPTÓ LA SOLICITUD DE REGISTRO (NDA) PARA TARLA OTORGÁNDOLE ADEMAS LA REVISIÓN PRIORITARIA . LA EMA TAMBIÉN LO ESTÁ YA EVALUANDO . Length: 576 characters | |
| Meta Keywords | Meta Keywords tips for pharma-jonpi.blogspot.com.es: The era of keyword-stuffed meta descriptions has passed; instead, focus your meta description on compelling, concise copy that encourages clicks from the organic search results pages, incorporating primary keywords naturally. |
| no meta keywords data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| Page Content | Page Content tips for pharma-jonpi.blogspot.com.es: Structure your content logically using clear headings and subheadings (H1-H6) to enhance readability for users and help search engines crawl and understand your page content structure more effectively. |
| Web Page Content Length: 2024836 characters | |
| H1 Heading | H1 Heading tips for pharma-jonpi.blogspot.com.es: While search algorithms have evolved beyond simple H1 counting, they continue to heavily weigh the presence, placement, and relevance of the primary heading when assessing page topical relevance for specific search queries. |
| Pharma Jonpi . / 1.1 / . FDA Approves Keytruda Qlex Subcutaneous Injection for Adult and Pediatric Patients With Solid Tumors KEYTRUDA Shows Survival Edge Over TECENTRIQ, OPDIVO in Older Patients With LUNG Cancer . Count: 3 heading tag | |
| H2 Headings | H2 Headings tips for pharma-jonpi.blogspot.com.es: The frequency and relevance of H2 tags directly influence how search engines interpret page authority and topical relevance; well-structured H2 usage reinforces the main content theme and provides strong context for related sub-topics to gain visibility. |
| 21 noviembre 2025 20 noviembre 2025 19 noviembre 2025 18 noviembre 2025 17 noviembre 2025 16 noviembre 2025 14 noviembre 2025 Twitter @pharma_jonpi: Para Buscar en este Blog : ACUERDOS ALCANZADOS . Archivo del blog En tres lineas ... ENLACES Count: 13 heading tag | |
| H3 Headings | H3 Headings tips for pharma-jonpi.blogspot.com.es: Strategically position descriptive H3 headers throughout your content to break up large blocks of text, improve user engagement by signaling key points, and enhance the semantic structure recognized by search engine crawlers. |
| PHARMAMAR .///. EN ESPAÑA CABILDEROS , PRENSA , ANALISTAS , FONDOS ... PASAN OLÍMPICAMENTE DE PUBLICAR LA APROBACIÓN COMPLETA DEL TARLATAMAB ( IMDELLTRA BY AMGEN ) EN ESTADOS UNIDOS PARA EL TRATAMIENTO DE SEGUNDA LÍNEA SMALL CELL LUNG CANCER EXTENSIVE-STAGE .///. A LO MEJOR DUDAN EN PUBLICARLO ... PORQUE TARLATAMAB TAN SOLO APORTA EL DOBLE DE SUPERVIVENCIA GLOBAL QUE LURBINECTEDIN . TARLATAMAB ( IMDELLTRA BY AMGEN ) RECEIVE FULL APPROVAL BY USFDA IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER . ESTÁ TAMBIÉN APROBADO EN CANADA , COREA , REINO UNIDO ... Y EN DIAS PODRIA SER APROBADO TAMBIÉN EN CHINA Y EUROPA .///. MIENTRAS LURBINECTEDIN SIGUE SIN FULL APPROVAL EN SEGUNDA LÍNEA SCLC-ES ... ESTÁ EN VARIOS MERCADOS CON UNA APROBACIÓN CONDICIONADA A LA ESPERA DE PODER CONCLUIR LA FASE III LAGOON ... TARLATAMAB ( IMDELLTRA BY AMGEN ) ACABA DE OBTENER EL FULL APPROVAL ( APROBACIÓN COMPLETA ) PARA EL TRATAMIENTO DE SMALL CELL LUNG CANCER EXTENSIVE-STAGE DE SEGUNDA LÍNEA ... REDUCE EL RIESGO DE MUERTE EN UN 40% VERSUS LA QUIMIO Y APORTA 13.6 MESES DE OVERALL SURVIVAL VERSUS LOS 8.3 QUE APORTA LURBINECTEDIN . POR FIN LLEGA LA INMUNOTERAPIA ADMINISTRADA VÍA SUBCUTÁNEA ... LO HA CONSEGUIDO MERCK CON KEYTRUDA ( PEMBROLIZUMAB SUBCUTANEA ) . TRAS EL OK DE LA FDA ... LLEGA AHORA EL OK DE LA EMA PARA EUROPA ... IAG PAGARÁ UN DIVIDENDO DE 0,0389 EUROS NETOS POR ACCIÓN EL PRÓXIMO 1 DE DICIEMBRE 2025 ///.../// Y ANUNCIA OTRO PAGO DE DIVIDENDO ADICIONAL A COBRAR EN FEBRERO 2026 . BERNSTEIN APUESTA POR IAG : DE QUEDARSE CON TAP ... BERNSTEIN CREE QUE NO IMPEDIRÍA LA CAPACIDAD DE IAG PARA DEVOLVER EFECTIVO A LOS ACCIONISTAS . POSIBLE TRATAMIENTO DE MANTENIMIENTO EN PRIMERA LINEA SMALL CELL LUNG CANCER EXTENSIVE-STAGE CON ATEZOLIZUMAB BY ROCHE Y TERAPIA GENICA DE GENPREX / REQORSA . HOY COMUNICAN LA OBTENCIÓN DE UNA PATENTE US QUE CUBRE EL TRATAMIENTO HASTA 2037 . IMDELLTRA ( TARLATAMAB BY AMGEN ) . IAG ENTRA EN FASE DE CAJA RÉCORD QUE CONVENCE A LOS ANALISTAS ... DEUTSCHE BANK ACABA DE CONFIRMAR Y ELEVAR SU CONFIANZA EN IAG ELEVANDO SU PRECIO OBJETIVO HASTA LOS 5.64 EUROS . En el Ensayo IMFORTE se Descartaron a los Pacientes con Enfermedad Refractaria, Que Representan un Subgrupo de Hasta el 20 % de los Pacientes ... DOCTOR RUDIN VE IMFORTE COMO UN TRATAMIENTO MINORITARIO ... Y NO ESTÁ SEGURO DE QUE VAYA A CAMBIAR LA PRÁCTICA CLÍNICA TANTO COMO LE GUSTARÍA . JAZZ PHARMACEUTICALS Sube en la Preapertura US Debido a la Obtención de Resultados Intermedios Positivos en la FASE III CON ZIIHERA Que de Confirmarse JAZZPHARMA Podría Solicitar Autorización Regulatoria Antes de Finalizar Junio 2026 . 17 NOVIEMBRE . DÍA MUNDIAL CANCER DE PULMÓN . HAY UNA TERAPIA QUE EVITARIA DESARROLLAR SMALL CELL LUNG CANCER EN LA MAYORIA DE LOS CASOS ... Y ES NO FUMAR O BIEN DEJAR DE FUMAR YA !!! . TABACALERAS Y FARMACÉUTICAS HACEN LO QUE PUEDEN ... PERO LA DECISIÓN ES SOLO TUYA ... SI CREES TENER ALGÚN SÍNTOMA NO DUDES EN ACUDIR A TU DOCTOR@ DE CONFIANZA . PEMBROLIZUMAB ( KEYTRUDA BY MERCK ) APORTA UN + 33% DE OVERALL SURVIVAL EN COMPARACIÓN CON ATEZOLIZUMAB ( TECENTRIQ BY ROCHE ) EN PACIENTES MAYORES CON CÁNCER DE PULMÓN ( NSCLC ) . CHINA . NORMAN NG : ANLOTINIB HYDROCHLORIDE CAPSULES AND BENMELSTOBART INJECTION ... UNA NUEVA OPORTUNIDAD DE TRATAMIENTO DE PRIMERA LÍNEA PARA PACIENTES CON SMALL CELL LUNG CANCER EXTENSIVE-STAGE EN HONG KONG . Count: 13 heading tag | |
| H4 Headings | H4 Headings tips for pharma-jonpi.blogspot.com.es: Structured Q&A sections on informational pages utilize H4 tags to clearly present questions and dedicated answers, enhancing user experience and directly addressing common search queries. |
| no h4 headings data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| H5-H6 Headings | H5-H6 Headings tips for pharma-jonpi.blogspot.com.es: Ensure H5 and H6 tags are used consistently across your site for similar content types, reinforcing a predictable structure that both users and search engines expect. |
| no h5-h6 headings data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| Image ALT Attributes | Image ALT Attributes tips for pharma-jonpi.blogspot.com.es: Properly implemented ALT attributes enhance the semantic structure of your webpage, contributing positively to its overall SEO health and ranking potential in search results. |
| https://blogger.googleusercontent.com/img/a/AVvXsEg7t28vAMUmyy74sa1GRH5q8EsN4b2avYOEiKCDWDClwjwSy_h3D9jN5Ot5bpwE3wVgGcqcXzW1pUD8eqVLdGLfy0UhhM_t-JTlmARoIMkAftKkI8K3bkVyKx8yDRKXpOeF0YantYgdrcYoVOvnGtnYY4vb0shqqebAYWjuwG11-qfqnY5ZLbqarQ=s222 Count: 1 images with ALT attributes | |
| Robots.txt | Robots.txt tips for pharma-jonpi.blogspot.com.es: Implementing proper robots.txt rules is vital for SEO by blocking non-essential crawling of duplicate content, low-value pages, or irrelevant site sections, thereby directing crawl budget towards important, unique, and indexable content that attracts organic traffic. |
| file robots.txt was found on the website | |
| XML Sitemap | XML Sitemap tips for pharma-jonpi.blogspot.com.es: Submitting a well-structured, XML sitemap to Google Search Console is a fundamental SEO practice for guiding search engines like Google, Bing, and Yahoo efficiently to all crucial pages on your website, ensuring they discover and index content that matters most to users and search rankings. |
| no xml sitemap data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| Page Size | Page Size tips for pharma-jonpi.blogspot.com.es: Thoroughly test any changes made to optimize page size by monitoring the resulting load time and user engagement metrics to ensure improvements are effective and positively impacting your website's overall performance and user experience. |
| page size: 1977 kb | |
| Response Time | Response Time tips for pharma-jonpi.blogspot.com.es: Employing server response compression and efficient image serving techniques can significantly cut down the time taken to receive the initial bytes from your server, directly improving perceived website speed and aiding SEO factors related to performance |
| response time: 1.630 sec | |
| Minify CSS | Minify CSS tips for pharma-jonpi.blogspot.com.es: Optimize website speed by minifying CSS files to their smallest possible size through the systematic removal of whitespace, unused selectors, and comments; this action directly contributes to faster Core Web Vitals, better indexing, improved SEO ranking, and a more satisfying user experience for all visitors. |
| Minified: https://www.blogger.com/static/v1/widgets/4128112664-css_bundle_v2.css https://www.blogger.com/dyn-css/authorization.css?targetBlogID=34154861&zx=724ae946-f564-4e68-ba2b-48c7e7ccaab3 https://www.blogger.com/dyn-css/authorization.css?targetBlogID=34154861&zx=724ae946-f564-4e68-ba2b-48c7e7ccaab3 included in the page | |
| Minify JavaScript | Minify JavaScript tips for pharma-jonpi.blogspot.com.es: Consider using automated tools to consistently minify all client-side JavaScript files, ensuring that your website delivers optimized code to users, which not only speeds up rendering but also aligns with SEO best practices for faster, more efficient web performance. |
| Minified: https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-9259956283784553&host=ca-host-pub-1556223355139109 https://www.blogger.com/static/v1/widgets/2792570969-widgets.js Unminified: /js/cookienotice.js detected during site scan | |
| Structured Data | Structured Data tips for pharma-jonpi.blogspot.com.es: Rich search features derived from Schema.org metadata, including review stars, pricing, availability, or event dates, provide significant competitive advantages, attracting more user interest and driving traffic directly to your website from search engine result pages. |
| no structured data data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| CDN Usage | CDN Usage tips for pharma-jonpi.blogspot.com.es: For websites with user-generated content like images or downloadable files stored on a server, integrate the CDN to serve these resources faster, reducing server load associated with serving these assets directly, especially for frequently shared files. |
| no cdn usage data for pharma-jonpi.blogspot.com.es 2026-08-15T07:05:38+00:00 | |
| SSL certificates | SSL certificates tips for pharma-jonpi.blogspot.com.es: Securing your website with SSL/TLS (Transport Layer Security, the successor to SSL) is a core best practice for website security and SEO, ensuring sensitive information is protected and meeting user expectations for online safety which indirectly contributes to engagement and conversions. |
| SSL is enabled on the website |
Estimated Traffic
| Minimum Daily Unique Visitors: | 2 484 |
| Minimum Daily Visits: | 2 903 |
| Minimum Daily Page Views: | 4 998 |
| Minimum Monthly Unique Visitors: | 74 520 |
| Minimum Monthly Visits: | 87 090 |
| Minimum Monthly Page Views: | 149 940 |
| Minimum Yearly Unique Visitors: | 894 240 |
| Minimum Yearly Visits: | 1 045 080 |
| Minimum Yearly Page Views: | 1 799 280 |
| Maximum Daily Unique Visitors: | 3 143 |
| Maximum Daily Visits: | 3 352 |
| Maximum Daily Page Views: | 5 657 |
| Maximum Monthly Unique Visitors: | 94 290 |
| Maximum Monthly Visits: | 100 560 |
| Maximum Monthly Page Views: | 169 710 |
| Maximum Yearly Unique Visitors: | 1 131 480 |
| Maximum Yearly Visits: | 1 206 720 |
| Maximum Yearly Page Views: | 2 036 520 |
Estimated Valuation
| Daily Revenue: | US$ 4 - 8 |
| Monthly Revenue: | US$ 120 - 240 |
| Yearly Revenue: | US$ 1 440 - 2 880 |
Estimated Worth
| Minimum: | US$ 2 160 |
| Maximum: | US$ 8 640 |
Similarly Ranked Sites
| Rank | Points | |
|---|---|---|
| 709 568 | 9 634 651 | |
| 709 569 | 9 634 650 | |
| 709 570 | 9 634 650 | |
| 709 571 | 9 634 649 | |
| 709 572 | 9 634 648 | |
| pharma-jonpi.blogspot.com.es | 709 573 | 9 634 647 |
| 709 574 | 9 634 647 | |
| 709 575 | 9 634 646 | |
| 709 576 | 9 634 645 | |
| 709 577 | 9 634 644 | |
| 709 578 | 9 634 644 |